z-logo
open-access-imgOpen Access
Serum granulysin is a marker for Th1 type immunity in pre‐eclampsia
Author(s) -
Sakai M.,
Ogawa K.,
Shiozaki A.,
Yoneda S.,
Sasaki Y.,
Nagata K.,
Saito S.
Publication year - 2004
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.2004.02414.x
Subject(s) - granulysin , immunology , cytotoxic t cell , biology , cellular immunity , immunity , medicine , immune system , perforin , cd8 , biochemistry , in vitro
SUMMARY Recent studies suggest that pre‐eclampsia is associated with a Th1 predominant state and may be considered a failure of tolerance. Granulysin is a cytotoxic granule protein of natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). Recently, we developed an enzyme‐linked immunosorbent assay (ELISA) system for detecting serum granulysin, and reported that serum granulysin is a useful marker to evaluate the cell‐mediated immunity. In this study, we show that the serum levels of granulysin were significantly elevated in pre‐eclamptic patients compared with those in normal pregnancy subjects. In addition, the serum granulysin levels in pre‐eclamptic patients were well associated with mean blood pressure, percentage of peripheral blood Th1 cells and Th1/Th2 ratios. The present results suggest that the serum granulysin levels would be a useful and novel serum marker to evaluate the Th1/Th2 balance, especially Th1 type immunity in pre‐eclampsia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom